John E. Kerrigan
Impact in
- Toxicology top 2%
- Cancer Research top 10%
Papers in
-
- Cancer, Hypoxia, and Metabolism 5
- Synthesis and Biological Activity 4
-
- Biochemical and Molecular Research 5
- RNA Interference and Gene Delivery 5
- Cancer therapeutics and mechanisms 5
- Protein Kinase Regulation and GTPase Signaling 4
- RNA modifications and cancer 4
- Co-authors
- Daniel S. Pilch (8 shared papers)Leroy F. Liu (5 shared papers)Yi Lisa Lyu (3 shared papers)Yuan‐Chin Tsai (2 shared papers)Chao‐Po Lin (2 shared papers)Yi Ban (1 shared paper)Anna M. Azarova (1 shared paper)Malvika Kaul (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Medicinal Chemistry (3 papers)Oncotarget (3 papers)Journal of Biological Chemistry (3 papers)Cancer Biology & Therapy (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
John E. Kerrigan
58 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 116
- Toxicology 89
- Cancer Research 270
- Physiology 88
- Molecular Biology 1.3k
- Cardiology and Cardiovascular Medicine 364
Countries citing papers authored by John E. Kerrigan
This map shows the geographic impact of John E. Kerrigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Kerrigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Kerrigan more than expected).
Fields of papers citing papers by John E. Kerrigan
This network shows the impact of papers produced by John E. Kerrigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Kerrigan. The network helps show where John E. Kerrigan may publish in the future.
Co-authors
The 25 scholars most cited alongside John E. Kerrigan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 509 | |
| 2 | 2013 | 178 | |
| 3 | 2003 | 109 | |
| 4 | 2016 | 74 | |
| 5 | 2016 | 72 | |
| 6 | 2006 | 70 | |
| 7 | 2015 | 69 | |
| 8 | 2013 | 65 | |
| 9 | 2001 | 65 | |
| 10 | 1998 | 64 | |
| 11 | 2004 | 63 | |
| 12 | 2003 | 58 | |
| 13 | 2012 | 57 | |
| 14 | 1992 | 55 | |
| 15 | 2016 | 51 | |
| 16 | 1994 | 49 | |
| 17 | 2011 | 46 | |
| 18 | 2009 | 43 | |
| 19 | 2005 | 39 | |
| 20 | 1995 | 38 |
About John E. Kerrigan
John E. Kerrigan is a scholar working on Cancer Research, Molecular Biology, Oncology, Organic Chemistry and Molecular Medicine, having authored 58 papers that have together received 2.3k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (5 papers), RNA Interference and Gene Delivery (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer therapeutics and mechanisms (5 papers), Synthesis and Biological Evaluation (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), RNA modifications and cancer (4 papers) and Synthesis and Biological Activity (4 papers). The work is most often cited by research in Toxicology (89 citations), Cancer Research (270 citations), Physiology (88 citations), Molecular Biology (1.3k citations) and Cardiology and Cardiovascular Medicine (364 citations). John E. Kerrigan has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Daniel S. Pilch, Leroy F. Liu, Yi Lisa Lyu, Yuan‐Chin Tsai, Chao‐Po Lin, Yi Ban, Anna M. Azarova, Malvika Kaul, Joseph R. Bertino and Christopher M. Barbieri. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Oncotarget, Journal of Biological Chemistry and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.